Evaluation of the pharmacological involvement of ATP-sensitive potassium (KATP) channels in the antidepressant-like effects of topiramate on mice

  • Saeed Shakiba
  • Mehdi Rezaee
  • Khashayar Afshari
  • Kiarash Kazemi
  • Khadijeh-alsadat Sharifi
  • Nazgol-Sadat Haddadi
  • Arvin Haj-Mirzaian
  • Aida Kamalian
  • Seyedeh Zarifeh Jazaeri
  • Kent Richter
  • Ahmad Reza DehpourEmail author
Original Article


Acute doses of topiramate (TPM) have been shown to reduce immobility time in the mice forced swimming test (FST) through inhibition of the nitric oxide (NO) pathway. Adenosine triphosphate–sensitive potassium (KATP) channels are known to have an active role in depression. This study investigates the potential participation of KATP channels in the antidepressant-like effect of TPM through the stimulatory effects of NO. FST and tail suspension tests (TST) were applied to adult male mice for assessment of the antidepressant-like activity of TPM. Different doses of glibenclamide and cromakalim were also applied in order to investigate the involvement of KATP channels. Fluoxetine was used as a positive control for evaluation of antidepressant-like effects. In addition, each animal’s locomotor activity was evaluated by the open-field test (OFT). TPM (30 mg/kg intraperitoneal (i.p.)) had a significant reductive effect on the immobility behavior similar to fluoxetine (20 mg/kg). Co-administration of sub-effective doses of glibenclamide (1 mg/kg i.p.) and TPM (10 mg/kg i.p.) led to significant synergistic effects in FST and TST. Additionally, the results showed that administration of the sub-effective dose of cromakalim (0.1 and 0.3 mg/kg i.p.) blocked the antidepressant-like effects of TPM (30 mg/kg i.p.) in both tests. These interventions had no impact on the locomotor movement of mice in OFT. This study shows that the antidepressant-like activity of TPM may potentially be mediated by the blocking of the KATP channels.


Topiramate Depression ATP-sensitive potassium channels Forced swimming test Tail suspension test Mice 


Authors’ contribution

AD and SS conceived and designed research. SS, MR, KA, KK, KS and NS, and AH and SJ conducted experiments and contributed in writing the manuscript. KA and MR analyzed the data. KR performed the final language editing of the manuscript in addition to reviewing and revising the whole content. All authors read and approved the manuscript.

Funding information

This study was financially supported by the Experimental Medicine Research Center, Tehran University of Medical Sciences (Grant No. 95-04-139-33933) and by a grant (96002757) from the Iran National Science Foundation.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.


  1. Appolinario JC, Fontenelle LF, Papelbaum M, Bueno JR, Coutinho W (2002) Topiramate use in obese patients with binge eating disorder: an open study. Can J Psychiatr 47:271–273CrossRefGoogle Scholar
  2. Armstead W (1996) Role of ATP-sensitive K+ channels in cGMP-mediated pial artery vasodilation. Am J Phys Heart Circ Phys 270:H423–H426Google Scholar
  3. Berton O, Nestler EJ (2006) New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 7:137–151CrossRefPubMedGoogle Scholar
  4. Blier P, De Montigny C (1994) Current advances and trends in the treatment of depression. Trends Pharmacol Sci 15:220–226CrossRefPubMedGoogle Scholar
  5. Bolotina VM, Najibi S, Palacino JJ, Pagano PJ, and Cohen RA (1994) Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 368(6474):850. Link for 1:
  6. Bourin M, Chenu F, Hascoët M (2009) Topiramate and phenytoin anti-immobility effect in the mice forced swimming test is reversed by veratrine: implication for bipolar depression treatment. Behav Brain Res 205:421–425CrossRefPubMedGoogle Scholar
  7. Briley M, Moret C (1993) Neurobiological mechanisms involved in antidepressant therapies. Clin Neuropharmacol 16:387–400CrossRefPubMedGoogle Scholar
  8. Coomans C, Geerling J, Berg S, Diepen H, Garcia-Tardón N, Thomas A, Schröder-van der Elst J, Ouwens D, Pijl H, Rensen P (2013) The insulin sensitizing effect of topiramate involves KATP channel activation in the central nervous system. Br J Pharmacol 170:908–918CrossRefPubMedPubMedCentralGoogle Scholar
  9. Cryan JF, Markou A, Lucki I (2002) Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 23:238–245CrossRefPubMedGoogle Scholar
  10. Davies AG, Pierce-Shimomura JT, Kim H, VanHoven MK, Thiele TR, Bonci A, Bargmann CI, McIntire SL (2003) A central role of the BK potassium channel in behavioral responses to ethanol in C. elegans. Cell 115:655–666CrossRefPubMedGoogle Scholar
  11. Delgado P, Moreno F (1999) Antidepressants and the brain. Int Clin Psychopharmacol 14:S9–S16CrossRefPubMedGoogle Scholar
  12. Dodgson SJ, Shank RP, Maryanoff BE (2000) Topiramate as an inhibitor of carbonic anhydrase isoenzymes. Epilepsia 41:35–39CrossRefGoogle Scholar
  13. Esposito E (2006) Serotonin-dopamine interaction as a focus of novel antidepressant drugs. Curr Drug Targets 7:177–185CrossRefPubMedGoogle Scholar
  14. Fan Y, Kong H, Ye X, Ding J, Hu G (2016) ATP-sensitive potassium channels: uncovering novel targets for treating depression. Brain Struct Funct 221:3111–3122CrossRefPubMedGoogle Scholar
  15. Fujino K, Nakaya S, Wakatsuki T, Miyoshi Y, Nakaya Y, Mori H, Inoue I (1991) Effects of nitroglycerin on ATP-induced Ca (++)-mobilization, Ca (++)-activated K channels and contraction of cultured smooth muscle cells of porcine coronary artery. J Pharmacol Exp Ther 256:371–377PubMedGoogle Scholar
  16. Galeotti N, Ghelardini C, Caldari B, Bartolini A (1999) Effect of potassium channel modulators in mouse forced swimming test. Br J Pharmacol 126:1653–1659CrossRefPubMedPubMedCentralGoogle Scholar
  17. Galicia SC, Lewis SL, Metman LV (2005) Severe topiramate-associated hyperthermia resulting in persistent neurological dysfunction. Clin Neuropharmacol 28:94–95CrossRefPubMedGoogle Scholar
  18. Gibbs JW, Sombati S, DeLorenzo RJ, Coulter DA (2000) Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neurons. Epilepsia 41:10–16CrossRefGoogle Scholar
  19. Glauser TA (1999) Topiramate. Epilepsia 40:s71–s80CrossRefPubMedGoogle Scholar
  20. Guo W, Todd K, Bourin M, Hascoet M, Kouadio F (1996) Additive effects of glyburide and antidepressants in the forced swimming test: evidence for the involvement of potassium channel blockade. Pharmacol Biochem Behav 54:725–730CrossRefPubMedGoogle Scholar
  21. Haj-Mirzaian A, Ostadhadi S, Kordjazy N, Dehpour AR, Mehr SE (2014) Opioid/NMDA receptors blockade reverses the depressant-like behavior of foot shock stress in the mouse forced swimming test. Eur J Pharmacol 735:26–31CrossRefPubMedGoogle Scholar
  22. Haj-Mirzaian A, Kordjazy N, Haj-Mirzaian A, Ostadhadi S, Ghasemi M, Amiri S, Faizi M, Dehpour A (2015) Evidence for the involvement of NMDA receptors in the antidepressant-like effect of nicotine in mouse forced swimming and tail suspension tests. Psychopharmacology 232:3551–3561CrossRefPubMedGoogle Scholar
  23. Haj-Mirzaian A, Kordjazy N, Ostadhadi S, Amiri S, Haj-Mirzaian A, Dehpour A (2016) Fluoxetine reverses the behavioral despair induced by neurogenic stress in mice: role of N-methyl-d-aspartate and opioid receptors. Can J Physiol Pharmacol 94:599–612CrossRefPubMedGoogle Scholar
  24. Hargreaves GA, McGregor IS (2007) Topiramate moderately reduces the motivation to consume alcohol and has a marked antidepressant effect in rats. Alcohol Clin Exp Res 31:1900–1907CrossRefPubMedGoogle Scholar
  25. Herrero AI, Del Olmo N, González-Escalada JR, Solı́s JM (2002) Two new actions of topiramate: inhibition of depolarizing GABA A-mediated responses and activation of a potassium conductance. Neuropharmacology 42:210–220CrossRefPubMedGoogle Scholar
  26. Inan SY, Yalcin I, Aksu F (2004) Dual effects of nitric oxide in the mouse forced swimming test: possible contribution of nitric oxide-mediated serotonin release and potassium channel modulation. Pharmacol Biochem Behav 77:457–464CrossRefPubMedGoogle Scholar
  27. Jeong SY, Ha TS, Park CS, Uhm DY, Chung S (2001) Nitric oxide directly activates large conductance Ca 2+-activated K+ channels (rSlo). Mol Cell (Springer Science & Business Media BV) 12(1)Google Scholar
  28. Jesse CR, Wilhelm EA, Barbosa NB, Nogueira CW (2009) Involvement of different types of potassium channels in the antidepressant-like effect of tramadol in the mouse forced swimming test. Eur J Pharmacol 613:74–78CrossRefPubMedGoogle Scholar
  29. Kaster MP, Ferreira PK, Santos AR, Rodrigues AL (2005) Effects of potassium channel inhibitors in the forced swimming test: possible involvement of L-arginine-nitric oxide-soluble guanylate cyclase pathway. Behav Brain Res 165:204–209CrossRefPubMedGoogle Scholar
  30. Khaloo P, Sadeghi B, Ostadhadi S, Norouzi-Javidan A, Haj-Mirzaian A, Zolfagharie S, Dehpour AR (2016) Lithium attenuated the behavioral despair induced by acute neurogenic stress through blockade of opioid receptors in mice. Biomed Pharmacother 83:1006–1015CrossRefPubMedGoogle Scholar
  31. Kobayashi T, Washiyama K, Ikeda K (2006) Inhibition of G protein-activated inwardly rectifying K+ channels by the antidepressant paroxetine. J Pharmacol Sci 102:278–287CrossRefPubMedGoogle Scholar
  32. Kobayashi T, Hirai H, Iino M, Fuse I, Mitsumura K, Washiyama K, Kasai S, Ikeda K (2009) Inhibitory effects of the antiepileptic drug ethosuximide on G protein-activated inwardly rectifying K+ channels. Neuropharmacology 56:499–506CrossRefPubMedGoogle Scholar
  33. Kordjazy N, Haj-Mirzaian A, Amiri S, Ostadhadi S, Kordjazy M, Sharifzadeh M, Dehpour AR (2015) Elevated level of nitric oxide mediates the anti-depressant effect of rubidium chloride in mice. Eur J Pharmacol 762:411–418CrossRefPubMedGoogle Scholar
  34. Kordjazy N, Haj-Mirzaian A, Amiri S, Ostadhadi S, Amini-khoei H, Dehpour AR (2016) Involvement of N-methyl-d-aspartate receptors in the antidepressant-like effect of 5-hydroxytryptamine 3 antagonists in mouse forced swimming test and tail suspension test. Pharmacol Biochem Behav 141:1–9CrossRefPubMedGoogle Scholar
  35. Lambert G, Johansson M, Ågren H, Friberg P (2000) Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness: evidence in support of the catecholamine hypothesis of mood disorders. Arch Gen Psychiatry 57:787–793CrossRefPubMedGoogle Scholar
  36. Maidment ID (2002) The use of topiramate in mood stabilization. Ann Pharmacother 36:1277–1281CrossRefPubMedGoogle Scholar
  37. Marcotte D (1998) Use of topiramate, a new anti-epileptic as a mood stabilizer. J Affect Disord 50:245–251CrossRefPubMedGoogle Scholar
  38. Millan MJ (2006) Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application. Pharmacol Ther 110:135–370CrossRefPubMedGoogle Scholar
  39. Nikoui V, Ostadhadi S, Azhand P, Zolfaghari S, Amiri S, Foroohandeh M, Motevalian M, Sharifi AM, Bakhtiarian A (2016) The effect of nitrazepam on depression and curiosity in behavioral tests in mice: the role of potassium channels. Eur J Pharmacol 791:369–376CrossRefPubMedGoogle Scholar
  40. Nutt DJ (2007) Relationship of neurotransmitters to the symptoms of major depressive disorder. J Clin Psychiatry 69:4–7Google Scholar
  41. Ostadhadi S, Haj-Mirzaian A, Nikoui V, Kordjazy N, Dehpour AR (2015) Involvement of opioid system in antidepressant-like effect of the cannabinoid CB1 receptor inverse agonist AM-251 after physical stress in mice. Clinical and Experimental Pharmacology and PhysiologyGoogle Scholar
  42. Ostadhadi S, Ahangari M, Nikoui V, Norouzi-Javidan A, Zolfaghari S, Jazaeri F, Chamanara M, Akbarian R, Dehpour A-R (2016a) Pharmacological evidence for the involvement of the NMDA receptor and nitric oxide pathway in the antidepressant-like effect of lamotrigine in the mouse forced swimming test. Biomed Pharmacother 82:713–721CrossRefPubMedGoogle Scholar
  43. Ostadhadi S, Khan MI, Norouzi-Javidan A, Chamanara M, Jazaeri F, Zolfaghari S, Dehpour AR (2016) Involvement of NMDA receptors and L-arginine/nitric oxide/cyclic guanosine monophosphate pathway in the antidepressant-like effects of topiramate in mice forced swimming test. Brain Res Bull 122:62–70Google Scholar
  44. Ostadhadi S, Khan MI, Norouzi-Javidan A, Chamanara M, Jazaeri F, Zolfaghari S, Dehpour A-R (2016c) Involvement of NMDA receptors and L-arginine/nitric oxide/cyclic guanosine monophosphate pathway in the antidepressant-like effects of topiramate in mice forced swimming test. Brain Res Bull 122:62–70CrossRefPubMedGoogle Scholar
  45. Ostadhadi S, Akbarian R, Norouzi-Javidan A, Nikoui V, Zolfaghari S, Chamanara M, Dehpour A-R (2017) Possible involvement of ATP-sensitive potassium channels in the antidepressant-like effects of gabapentin in mouse forced swimming test. Can J Physiol Pharmacol 95:795–802CrossRefPubMedGoogle Scholar
  46. Papazian DM (1999) Potassium channels. Neuron 23:7–10CrossRefPubMedGoogle Scholar
  47. Pineda E, Shin D, Sankar R, Mazarati AM (2010) Comorbidity between epilepsy and depression: experimental evidence for the involvement of serotonergic, glucocorticoid, and neuroinflammatory mechanisms. Epilepsia 51:110–114CrossRefPubMedPubMedCentralGoogle Scholar
  48. Racagni G, Popoli M (2010) The pharmacological properties of antidepressants. Int Clin Psychopharmacol 25:117–131CrossRefPubMedGoogle Scholar
  49. Sankar R, Mazarati A (2012) Neurobiology of depression as a comorbidity of epilepsy. InJasper's Basic Mechanisms of the Epilepsies [Internet], 4th edn. National Center for Biotechnology Information (US)Google Scholar
  50. Seino S, Miki T (2003) Physiological and pathophysiological roles of ATP-sensitive K+ channels. Prog Biophys Mol Biol 81:133–176CrossRefPubMedGoogle Scholar
  51. Shin JH, Chung S, Park EJ, Uhm D-Y, Suh CK (1997) Nitric oxide directly activates calcium-activated potassium channels from rat brain reconstituted into planar lipid bilayer. FEBS Lett 415:299–302CrossRefPubMedGoogle Scholar
  52. Stahl SM, Stahl SM (2013) Stahl's essential psychopharmacology: neuroscientific basis and practical applications. Cambridge University PressGoogle Scholar
  53. Stella F, Caetano D, Cendes F, Guerreiro CA (2002) Acute psychotic disorders induced by topiramate: report of two cases. Arq Neuropsiquiatr 60:285–287CrossRefPubMedGoogle Scholar
  54. Taverna S, Sancini G, Mantegazza M, Franceschetti S, Avanzini G (1999) Inhibition of transient and persistent Na+ current fractions by the new anticonvulsant topiramate. J Pharmacol Exp Ther 288:960–968PubMedGoogle Scholar
  55. Von Seggern RL, Mannix LK, Adelman JU (2002) Efficacy of topiramate in migraine prophylaxis: a retrospective chart analysis. Headache 42:804–809CrossRefGoogle Scholar
  56. Wang R, Xu Y, Wu H-L, Li Y-B, Li Y-H, Guo J-B, Li X-J (2008) The antidepressant effects of curcumin in the forced swimming test involve 5-HT 1 and 5-HT 2 receptors. Eur J Pharmacol 578:43–50CrossRefPubMedGoogle Scholar
  57. White HS, Brown SD, Woodhead JH, Skeen GA, Wolf HH (1997) Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold. Epilepsy Res 28:167–179CrossRefPubMedGoogle Scholar
  58. White HS, Brown SD, Woodhead J, Skeen GA, Wolf HH (2000) Topiramate modulates GABA-evoked currents in murine cortical neurons by a nonbenzodiazepine mechanism. Epilepsia 41:17–20CrossRefGoogle Scholar
  59. Wickenden AD (2002) K+ channels as therapeutic drug targets. Pharmacol Ther 94:157–182CrossRefPubMedGoogle Scholar
  60. Wiegartz P, Seidenberg M, Woodard A, Gidal B, Hermann B (1999) Co-morbid psychiatric disorder in chronic epilepsy: recognition and etiology of depression. NeurologyGoogle Scholar
  61. Zhang X, Velumian AA, Jones OT, Carlen PL (2000) Modulation of high-voltage–activated calcium channels in dentate granule cells by topiramate. Epilepsia 41:52–60CrossRefGoogle Scholar
  62. Zona C, Ciotti MT, Avoli M (1997) Topiramate attenuates voltage-gated sodium currents in rat cerebellar granule cells. Neurosci Lett 231:123–126CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  • Saeed Shakiba
    • 1
    • 2
    • 3
  • Mehdi Rezaee
    • 4
  • Khashayar Afshari
    • 1
    • 2
    • 3
  • Kiarash Kazemi
    • 3
  • Khadijeh-alsadat Sharifi
    • 5
  • Nazgol-Sadat Haddadi
    • 2
    • 3
  • Arvin Haj-Mirzaian
    • 1
    • 2
  • Aida Kamalian
    • 2
    • 3
  • Seyedeh Zarifeh Jazaeri
    • 2
    • 3
  • Kent Richter
    • 6
  • Ahmad Reza Dehpour
    • 2
    • 7
    Email author
  1. 1.Brain and Spinal Cord Injury Research Center, Neuroscience InstituteTehran University of Medical SciencesTehranIran
  2. 2.Experimental Medicine Research CenterTehran University of Medical SciencesTehranIran
  3. 3.School of MedicineTehran University of Medical SciencesTehranIran
  4. 4.Anesthesiology DepartmentTehran University of Medical SciencesTehranIran
  5. 5.University of Virginia, School of MedicineCharlottesvilleUSA
  6. 6.Mayo Clinic Alix School of MedicineRochesterUSA
  7. 7.Tehran University of Medical SciencesTehranIran

Personalised recommendations